Tracker

CDSCO approvals

CDSCO's list of new drug and clinical trial approvals holds 244 permission letters dated 2020, from January 3, 2020 to December 30, 2020. GCT is the most common kind of permission, with 81. Each row gives the company, product, kind of permission, date and a link to the letter, and CDSCO's file number where its text gives it.

From CDSCO's CT Approvals list, read . Each product links to CDSCO's PDF of its letter. The date is the one CDSCO gives on its list; the file number is printed in the letter. Not stated: file number on 11 rows. The file number is not read from 92 scanned letters: we read a letter's text, not its image. CDSCO's link did not open for 1 letter, so its file number is not shown.

The kinds of permission are CDSCO's own. FDC is fixed-dose combination (CDSCO's guidance for its Subject Expert Committees, page 13); GCT is global clinical trial (CDSCO's FAQs on the New Drugs and Clinical Trials Rules, page 8); SND is Subsequent New Drugs (CDSCO's Citizen's Charter, page 2); rDNA is recombinant Deoxyribonucleic Acid (CDSCO's FAQs on the New Drugs and Clinical Trials Rules, page 3, which that page writes r-DNA).

December 2020

November 2020

October 2020

September 2020

August 2020

July 2020

June 2020

May 2020

April 2020

March 2020

February 2020

January 2020